| Item 1. | |
| (a) | Name of issuer:
Dynavax Technologies Corporation |
| (b) | Address of issuer's principal executive offices:
2100 Powell Street, Suite 720, Emeryville, CA 94608 |
| Item 2. | |
| (a) | Name of person filing:
(i) Deep Track Biotechnology Master Fund, Ltd.
(ii) Deep Track Capital, LP
(iii) David Kroin |
| (b) | Address or principal business office or, if none, residence:
(i) c/o Walkers Corporate Limited, 190 Elgin Ave, George Town, KY1-9001, Cayman Islands
(ii) 200 Greenwich Ave, 3rd Floor, Greenwich, CT 06830
(iii) c/o Deep Track Capital, LP, 200 Greenwich Ave, 3rd Floor, Greenwich, CT 06830 |
| (c) | Citizenship:
(i) Cayman Islands
(ii) Delaware
(iii) United States |
| (d) | Title of class of securities:
Common Stock, $0.001 par value |
| (e) | CUSIP No.:
268158201 |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) |  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
|
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
|
| | |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
|
| (b) | Percent of class:
|
| (c) | Number of shares as to which the person has:
|
| | (i) Sole power to vote or to direct the vote:
|
| | (ii) Shared power to vote or to direct the vote:
|
| | (iii) Sole power to dispose or to direct the disposition of:
|
| | (iv) Shared power to dispose or to direct the disposition of:
Information with respect to the Reporting Persons' ownership of the Common Stock as of August 22, 2025 is incorporated by reference to items (5) - (9) and (11) of the cover page of the respective Reporting Person.
The amount beneficially owned by each Reporting Person is determined based on 117,267,482 Common Stock outstanding, as reported on the Issuer's 10-Q filed August 7, 2025.
|
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
| |
Not Applicable
|
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
Not Applicable
|
| Item 8. | Identification and Classification of Members of the Group. |
| |
Not Applicable
|
| Item 9. | Notice of Dissolution of Group. |
| |
Not Applicable
|
Rule 13d-1(c)